Numeric Investors LLC trimmed its position in shares of PetMed Express, Inc. (NASDAQ:PETS) by 69.2% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 67,381 shares of the company’s stock after selling 151,700 shares during the quarter. Numeric Investors LLC owned approximately 0.33% of PetMed Express worth $2,736,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Pinebridge Investments L.P. boosted its position in PetMed Express by 1.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock valued at $110,000 after acquiring an additional 27 shares in the last quarter. Acrospire Investment Management LLC bought a new stake in PetMed Express during the 2nd quarter valued at approximately $110,000. State of Alaska Department of Revenue boosted its position in PetMed Express by 76.7% during the 2nd quarter. State of Alaska Department of Revenue now owns 4,028 shares of the company’s stock valued at $163,000 after acquiring an additional 1,748 shares in the last quarter. IMS Capital Management bought a new stake in PetMed Express during the 2nd quarter valued at approximately $216,000. Finally, Weatherly Asset Management L. P. bought a new stake in PetMed Express during the 2nd quarter valued at approximately $216,000. 78.91% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Robert C. Schweitzer sold 2,500 shares of the stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $49.18, for a total transaction of $122,950.00. Following the transaction, the director now directly owns 88,834 shares in the company, valued at $4,368,856.12. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Ronald J. Korn sold 5,000 shares of the stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $48.18, for a total transaction of $240,900.00. Following the transaction, the director now owns 67,333 shares in the company, valued at $3,244,103.94. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,333 shares of company stock worth $949,730. Insiders own 4.00% of the company’s stock.

Shares of PetMed Express, Inc. (PETS) opened at 35.16 on Friday. The company has a market capitalization of $713.47 million, a PE ratio of 27.05 and a beta of 1.03. The stock has a 50 day moving average price of $36.58 and a 200-day moving average price of $34.70. PetMed Express, Inc. has a 12 month low of $18.90 and a 12 month high of $50.90.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, July 24th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.07. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The firm had revenue of $79.66 million for the quarter, compared to the consensus estimate of $77.32 million. During the same period last year, the firm earned $0.32 earnings per share. The company’s quarterly revenue was up 9.9% on a year-over-year basis. Analysts forecast that PetMed Express, Inc. will post $1.44 EPS for the current year.

PETS has been the topic of several research reports. Northcoast Research raised PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price objective on the stock in a research report on Monday, July 24th. ValuEngine raised PetMed Express from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Sidoti raised PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price objective on the stock in a research report on Thursday, August 24th. BidaskClub cut PetMed Express from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, August 22nd. Finally, Zacks Investment Research cut PetMed Express from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 25th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. PetMed Express presently has a consensus rating of “Hold” and an average price target of $40.00.

COPYRIGHT VIOLATION WARNING: “Numeric Investors LLC Cuts Holdings in PetMed Express, Inc. (PETS)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/06/numeric-investors-llc-cuts-holdings-in-petmed-express-inc-pets.html.

PetMed Express Company Profile

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS).

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.